Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
EA
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PMT
2301
PennyMac Mortgage Investment
PMT
$810M
| $485K | ﹤0.01% |
41,595
-180,577
| -81% | -$2.23M |
|
2302
Forte Biosciences
FBRX
$1.63B
| $485K | ﹤0.01% |
+18,717
| New | +$539K |
|
2303
GE HealthCare
GEHC
$33.4B
| $484K | ﹤0.01% |
6,802
-12,342
| -64% | -$973K |
|
|
2304
PUT
RTX Corp
RTX
$283B
| $482K | ﹤0.01% |
2,500
-13,400
| -84% | -$2.66M |
|
2305
Vanguard FTSE Developed Markets ETF
VEA
$240B
| $481K | ﹤0.01% |
+7,500
| New | +$495K |
|
2306
The Bancorp
TBBK
$2.73B
| $480K | ﹤0.01% |
8,939
-2,544
| -22% | -$152K |
|
2307
Western Alliance Bancorporation
WAL
$8.69B
| $480K | ﹤0.01% |
6,771
-7,527
| -53% | -$627K |
|
2308
Xylem
XYL
$26.3B
| $480K | ﹤0.01% |
4,014
+63
| +2% | +$8.26K |
|
2309
SAP
SAP
$250B
| $479K | ﹤0.01% |
2,800
-123,922
| -98% | -$25.6M |
|
|
AMTM
2310
Amentum Holdings
AMTM
$4.95B
| $478K | ﹤0.01% |
18,345
-249,654
| -93% | -$7.83M |
|
2311
Otis Worldwide
OTIS
$27.2B
| $478K | ﹤0.01% |
6,199
-123,152
| -95% | -$10.8M |
|
2312
Hewlett Packard
HPE
$70.8B
| $472K | ﹤0.01% |
19,834
-3,543
| -15% | -$78.5K |
|
2313
Teladoc Health
TDOC
$1.12B
| $472K | ﹤0.01% |
86,638
+28,268
| +48% | +$159K |
|
2314
PUT
Monster Beverage
MNST
$95.5B
| $471K | ﹤0.01% |
13,000
-1,000
| -7% | -$39.4K |
|
2315
Angi Inc
ANGI
$200M
| $471K | ﹤0.01% |
+68,695
| New | +$689K |
|
2316
Gorman-Rupp
GRC
$2.03B
| $468K | ﹤0.01% |
+7,533
| New | +$445K |
|
2317
EnerSys
ENS
$7.01B
| $464K | ﹤0.01% |
2,671
+915
| +52% | +$155K |
|
2318
Byline Bancorp
BY
$1.72B
| $462K | ﹤0.01% |
+14,648
| New | +$460K |
|
2319
YPF Sociedad Anonima ADS
YPF
$19.6B
| $461K | ﹤0.01% |
+9,968
| New | +$377K |
|
2320
Maplebear
CART
$11.9B
| $460K | ﹤0.01% |
12,275
-15,957
| -57% | -$605K |
|
2321
Daktronics
DAKT
$923M
| $457K | ﹤0.01% |
+23,366
| New | +$533K |
|
2322
Atmos Energy
ATO
$28.3B
| $456K | ﹤0.01% |
2,469
-114
| -4% | -$20.1K |
|
2323
American Express Global Business Travel
GBTG
$4.95B
| $454K | ﹤0.01% |
81,437
-8,791
| -10% | -$54.6K |
|
2324
Cognex
CGNX
$10.1B
| $454K | ﹤0.01% |
+9,268
| New | +$433K |
|
2325
DTE Energy
DTE
$28.3B
| $453K | ﹤0.01% |
3,100
-1,077,864
| -100% | -$152M |
|
Similar funds
Dmitry Balyasny's Q1 2026 Portfolio in Review
As of Q1 2026, Dmitry Balyasny held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dmitry Balyasny withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in Silicon Laboratories worth $257M.
- Dmitry Balyasny's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Dmitry Balyasny added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Dmitry Balyasny's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Dmitry Balyasny fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Dmitry Balyasny's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Dmitry Balyasny opened 704 new positions and closed 911 in Q1 2026.
- Dmitry Balyasny's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.